Oncorus, Inc. (ONCR) Financial Statements (2026 and earlier)

Company Profile

Business Address 4 CORPORATE DRIVE
ANDOVER, MA 01810
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments25,709100,752130,305
Cash and cash equivalent25,709100,752130,305
Other undisclosed current assets38,90928,3583,086
Total current assets:64,618129,110133,391
Noncurrent Assets
Operating lease, right-of-use asset32,56045,21841,372
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization44,36023,2334,173
Restricted cash and investments  3,4372,877
Other noncurrent assets611589450
Other undisclosed noncurrent assets3,437  
Total noncurrent assets:80,96872,47748,872
TOTAL ASSETS:145,586201,587182,263
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,64219,2904,983
Accounts payable5,69413,0091,245
Accrued liabilities10,9486,2813,738
Debt19,436  
Other liabilities   8
Other undisclosed current liabilities1,1291,684993
Total current liabilities:37,20720,9745,984
Noncurrent Liabilities
Long-term debt and lease obligation:  50,38841,615
Liabilities, other than long-term debt47,854203 
Other liabilities  203 
Operating lease, liability47,85450,38841,615
Other undisclosed noncurrent liabilities   (41,615)
Total noncurrent liabilities:47,85450,59141,615
Total liabilities:85,06171,56547,599
Equity
Equity, attributable to parent60,525130,022134,664
Common stock332
Additional paid in capital332,583324,620264,487
Accumulated other comprehensive loss(52)(14) 
Accumulated deficit(272,009)(194,587)(129,825)
Total equity:60,525130,022134,664
TOTAL LIABILITIES AND EQUITY:145,586201,587182,263

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues
(gain on Disposition of Assets for Financial Service Operations)		   
Gross profit:   
Operating expenses(76,537)(64,818)(37,153)
Other undisclosed operating loss   
Operating loss:(76,537)(64,818)(37,153)
Nonoperating income (expense)(885)56(11,146)
Investment income, nonoperating  65143
Other nonoperating income (expense)210(9)(33)
Loss from continuing operations:(77,422)(64,762)(48,299)
Loss before gain (loss) on sale of properties:✕(64,762)(48,299)
Net loss attributable to parent:(77,422)(64,762)(48,299)
Preferred stock dividends and other adjustments   (8,527)
Net loss available to common stockholders, diluted:(77,422)(64,762)(56,826)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(77,422)(64,762)(48,299)
Other comprehensive income (loss)(38)(14) 
Comprehensive loss, net of tax, attributable to parent:(77,460)(64,776)(48,299)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: